Your session is about to expire
← Back to Search
Enoxaparin + Rosuvastatin for Blood Clot Prevention After Ovarian Cancer Surgery
Study Summary
This trial is testing whether or not the combination of these two drugs can help to prevent venous blood clots, which can lead to conditions such as deep vein thrombosis or pulmonary embolism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Enoxaparin + Rosuvastatin
- Group 2: Enoxaparin
- Group 3: Thromboprophylaxis
Frequently Asked Questions
Does the scientific literature feature any investigations combining Enoxaparin and Rosuvastatin?
"Currently, 19 Phase 3 trials are exploring the efficacy of Enoxaparin + Rosuvastatin with 59 total clinical studies in progress. While Bethesda Maryland hosts most research on this combination therapy, 692 sites across the world have been identified to conduct these experiments."
How risky is the combination of Enoxaparin and Rosuvastatin for patient health?
"Our team of experts at Power rated Enoxaparin and Rosuvastatin as a 2 on the safety scale due to its Phase 2 status, which implies that there is some data supporting protection but not efficacy."
What is the current participant count for this research endeavor?
"Presently, this medical trial is not enrolling participants. It was initially posted on July 25th 2018 and received its most recent update on October 13th 2022. Alternately, 677 studies are actively seeking patients with a carcinoma diagnosis while 59 trials for Enoxaparin + Rosuvastatin have openings available."
Are there still spots available for this research endeavor?
"This research study is no longer accepting applicants. The trial was initially posted on July 25th 2018, with the most recent modification made on October 13th 2022. If you are looking for additional studies, 677 clinical trials involving carcinoma and ovarian epithelial are presently recruiting candidates while 59 Enoxaparin + Rosuvastatin related studies demand participants as well."
Under what conditions is the combination of Enoxaparin and Rosuvastatin typically employed?
"Enoxaparin + Rosuvastatin is traditionally employed to address acute chest syndrome, though it can also prove useful in managing hypertriglyceridemias and cardiovascular disease (CVD) outside of a hospital setting."
Share this study with friends
Copy Link
Messenger